Valproate : PRAC non-interventional imposed PASS final study report assessment report - EMEA/H/N/PSR/J/0043

Valproate : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - EMEA/H/N/PSR/J/0043

Valproate : List of nationally authorised medicinal products - EMEA/H/N/PSR/J/0043

Human medicines European public assessment report (EPAR): Trecondi, treosulfan, Date of authorisation: 20/06/2019, Revision: 5, Status: Authorised

Herbal medicinal product: Fumariae herbaArray, F: Assessment finalised

Public-health advice during COVID-19 pandemic

Simplified summary - EMA/ECDC/EFSA fourth joint report on the integrated analysis of the antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU/EEA (JIACRA IV)

Multi-agency report highlights importance of reducing antibiotic use

EMA/ECDC/EFSA fourth joint report on the integrated analysis of the antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU/EEA (JIACRA IV)

Analysis of antimicrobial consumption and resistance ('JIACRA' reports)